Kidney Transplant Basics for CDN

Kidney Transplant Basics for CDN

Quick Answer: The NNCC CDN blueprint dedicates roughly 4–5% of scored content to kidney transplantation and acute therapies — a small slice that still produces predictable items on immunosuppressant classes, contraindications, rejection signs, and post-transplant infection risk. Master the drug families and the nursing red flags; those facts convert to points faster than re-reading another HD adequacy table.

Kidney transplantation is the preferred renal replacement therapy for eligible patients with end-stage kidney disease because it restores kidney function, improves quality of life, and extends survival compared with long-term dialysis alone. As a Certified Dialysis Nurse (CDN) candidate, you are not expected to function as a transplant coordinator, but you must understand how transplant fits the continuum of nephrology nursing — from pre-transplant education through post-transplant monitoring and graft failure returning a patient to dialysis.

Eligibility, Workup, and Contraindications

Transplant candidacy is determined by a multidisciplinary team including nephrology, transplant surgery, social work, finance, and often cardiology and psychiatry. Standard pre-transplant evaluation includes blood typing, human leukocyte antigen (HLA) matching, crossmatch testing, infectious-disease screening, cancer screening, cardiac risk assessment, and psychosocial readiness. A negative crossmatch means the recipient does not have preformed antibodies against the donor, reducing hyperacute rejection risk.

Exam trap: Diabetes and advanced age are frequently listed as answer choices beside true absolute contraindications. NNCC items reward knowing that active malignancy and active infection are the classic absolutes because immunosuppression accelerates cancer progression and prevents clearing serious infection.

Living Donor vs Deceased Donor

Living-donor kidneys generally offer superior graft survival, shorter wait times, and can be scheduled electively. Donors undergo rigorous medical and psychosocial screening; paired exchange programs help when blood types or crossmatches are incompatible. Deceased-donor kidneys remain the majority source nationally; allocation uses policies emphasizing compatibility, waiting time, and medical urgency. CDN questions may contrast expected outcomes or identify nursing education priorities — living donors need post-donation follow-up; recipients of any donor need lifelong immunosuppression adherence.

Immunosuppression Drug Classes

Modern maintenance regimens combine several agents to reduce rejection while limiting toxicity:

Tacrolimus is the calcineurin inhibitor most commonly tested. Sirolimus is the prototypical mTOR inhibitor. Do not confuse mTOR inhibitors with calcineurin inhibitors — both prevent rejection but through different pathways and with different side-effect profiles.

Rejection Types and Nursing Monitoring

Hyperacute rejection occurs within minutes to hours from preformed antibodies; it is rare with modern crossmatching. Acute rejection typically appears weeks to months post-transplant and presents with rising serum creatinine, decreased urine output, fever, graft tenderness, and hypertension. Chronic rejection is insidious graft dysfunction over years. Biopsy confirms rejection type and guides treatment — high-dose steroids, antithymocyte globulin, or regimen adjustment.

Nursing priorities after transplant include:

1. Strict intake and output with daily weights — sudden oliguria is an early rejection or obstruction signal.
2. Vital signs and pain assessment at the graft site.
3. Infection surveillance — immunosuppressed patients may have muted inflammatory responses.
4. Medication education — never stop immunosuppressants without transplant-team approval.
5. Lab monitoring: creatinine, immunosuppressant trough levels, CBC, electrolytes.

Post-Transplant Complications Beyond Rejection

Transplant recipients face surgical complications (bleeding, urine leak, vascular thrombosis), infections (UTI, CMV, BK virus nephropathy), cardiovascular disease, malignancy (especially skin cancer and lymphoproliferative disorders), and new-onset diabetes from corticosteroids and calcineurin inhibitors. When a graft fails, patients return to dialysis or may be re-listed — your dialysis-unit experience directly applies to their re-entry care.

Worked Scenario: Fever at Week 3

A 52-year-old kidney transplant recipient on tacrolimus, mycophenolate, and prednisone calls the dialysis clinic reporting fever of 101.8°F and decreased urine output. Correct nursing action: notify the transplant team immediately, do not advise stopping immunosuppressants, obtain orders for blood and urine cultures, and avoid treating fever as a minor viral illness. In the first 6 months, fever is opportunistic infection until proven otherwise — CMV, bacterial UTI, and aspiration pneumonia are common. This scenario pattern repeats on CDN forms because it tests safety judgment, not memorization of a single drug dose.

CDN Study Focus for Transplant

Memorize drug classes, absolute contraindications, acute rejection signs, and the infection-risk teaching point. Pair transplant review with your HD and PD chapters — many transplant recipients briefly dialyze pre-transplant or return post-graft-failure, so continuity-of-care questions are fair game on the NNCC exam.